[Metabolic imaging of a malignant myxofibrosarcoma with F-18-FDG and C-11-methionine positron emission tomography].
Weckesser
E
E
Klinik für Nuklearmedizin der Medizinischen Hochschule Hannover, Deutschland.
Redeker
J
J
Kühnel
G
G
Börner
A R
AR
Flügel
M
M
Knapp
W H
WH
D000368:Aged; D002250:Carbon Radioisotopes / Q000493:pharmacokinetics*; D003937:Diagnosis, Differential; D005354:Fibrosarcoma / Q000000981:diagnostic imaging* / Q000473:pathology / Q000601:surgery; D019788:Fluorodeoxyglucose F18 / Q000493:pharmacokinetics*; D006801:Humans; D008207:Lymphatic Metastasis / Q000000981:diagnostic imaging*; D008297:Male; D019275:Radiopharmaceuticals / Q000493:pharmacokinetics*; D013669:Technetium Tc 99m Medronate / Q000031:analogs & derivatives; D014018:Tissue Distribution; D014055:Tomography, Emission-Computed
D002250:Carbon Radioisotopes; D019275:Radiopharmaceuticals; D019788:Fluorodeoxyglucose F18; C024226:technetium Tc 99m hydroxymethylene diphosphonate; D013669:Technetium Tc 99m Medronate